Maximus (NYSE:MMS – Get Free Report) will post its quarterly earnings results after the market closes on Wednesday, May 8th. Analysts expect Maximus to post earnings of $1.30 per share for the quarter. Maximus has set its FY24 guidance at $5.20-5.50 EPS and its FY 2024 guidance at 5.200-5.500 EPS.Parties that are interested in participating in the company’s conference call can do so using this link.
Maximus (NYSE:MMS – Get Free Report) last announced its earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.06. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.94 EPS. On average, analysts expect Maximus to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.
Maximus Stock Performance
NYSE:MMS opened at $82.81 on Monday. Maximus has a 52 week low of $72.39 and a 52 week high of $89.69. The company has a fifty day simple moving average of $82.33 and a two-hundred day simple moving average of $81.51. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.71. The company has a market cap of $5.05 billion, a price-to-earnings ratio of 27.42 and a beta of 0.72.
Maximus Dividend Announcement
Insiders Place Their Bets
In other news, CFO David Mutryn sold 8,000 shares of the firm’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $83.95, for a total value of $671,600.00. Following the sale, the chief financial officer now directly owns 5,124 shares in the company, valued at approximately $430,159.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.40% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
Separately, StockNews.com raised Maximus from a “hold” rating to a “buy” rating in a research report on Thursday, February 8th.
Get Our Latest Report on Maximus
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
- Five stocks we like better than Maximus
- 3 Warren Buffett Stocks to Buy Now
- MarketBeat Week in Review – 4/29 – 5/3
- Consumer Staples Stocks, Explained
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Where to Find Earnings Call Transcripts
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.